Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Mangoceuticals, Inc. ( (MGRX) ) has provided an update.
On February 3, 2025, Mangoceuticals, Inc. entered into a Subscription Agreement with an accredited investor for the purchase of 70,000 shares of its restricted common stock at $1.50 per share, totaling $105,000. The transaction was exempt from registration under the Securities Act of 1933, involving no public offering or underwriters, and included customary representations and warranties. Additionally, on February 6, 2025, the company amended the employment agreement with COO Amanda Hammer, expanding her role to include Chief Operating Officer of its subsidiary, Mango & Peaches Corp. Her compensation was increased to $180,000 annually, effective February 1, 2025, and she was awarded a $15,000 cash bonus.
More about Mangoceuticals, Inc.
YTD Price Performance: 37.35%
Average Trading Volume: 79,317
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $8.5M
See more insights into MGRX stock on TipRanks’ Stock Analysis page.
